Parexel named “Best Contract Research Organization” at 19th Annual Scrip Awards
November 17, 2023 -
Parexel was named “Best Contract Research Organization” in the Full-Service Provider category at the 19th Annual Scrip Awards. Parexel was selected by a distinguished panel of life science industry executives based on the company’s capabilities and strengths in delivering results to exceed sponsor expectations; innovations in patient engagement and recruitment; commitment to diversity and inclusion in clinical trials and ability to leverage AI and RWE to evolve the clinical development process to better serve patients. The annual Scrip Awards, organized by Citeline, are designed to celebrate and recognize the very best innovations and achievements in global biopharma.
November 8, 2023 -
Parexel was recognized with the 2023 Healthcare Businesswomen’s Association’s (HBA) “Advancement. Commitment. Engagement (ACE) Award,” which recognizes companies for their creation and implementation of initiatives that deliver impactful outcomes designed to close the gender gap in the healthcare ecosystem. Parexel was one of two companies chosen as a result of the strong outcomes from its business initiative “Priority: Advancing Women in Leadership.” ACE Award recipients are selected by an independent panel of healthcare industry leaders for their demonstrated efficacy in advancing female talent. Award criteria include measurable results, business performance, stewardship, execution and sustainability.
Global Investigative Sites Recognize Parexel with the 2023 Society for Clinical Research Sites Eagle Award
October 12, 2023 -
Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced it has been awarded the 2023 Society for Clinical Research Sites (SCRS) Eagle Award (CRO category). Parexel received the award at the annual Global Site Solutions Summit held Oct. 6-8 in Hollywood, Fla. The SCRS Eagle Award recognizes the sponsor and CRO committed to outstanding leadership, professionalism, integrity, passion and dedication to advancing the clinical research profession through strong site partnerships.
Parexel rated “Top CRO to Work With” in 2023 WCG CenterWatch Survey for second straight time
May 31, 2023 -
Parexel has been rated the “Top CRO to Work With” by investigative sites worldwide in the 2023 WCG CenterWatch Global Site Relationship Benchmark Survey. Among the 34 CROs included in the survey, Parexel received the highest average rating across all 26 performance attributes evaluated. In addition to receiving the highest average rating across all attributes, Parexel ranked highest on four out of the five attributes considered the most important to investigative sites and was selected as the CRO that investigative sites were most willing to recommend to a colleague.